Lucintel Forecasts the Global Minimal Residual Disease Dynamic Monitor Market is expected to grow with a CAGR of 16.1% from 2025 to 2031
Lucintel Forecasts the Global Minimal Residual Disease Dynamic Monitor Market is expected to grow with a CAGR of 16.1% from 2025 to 2031
Blog Article
According to a market report by Lucintel, the future of the global minimal residual disease dynamic monitor market looks promising with opportunities in the adjuvant therapy testing, prognostic assessment, postoperative recurrence detection, and immunotherapy efficacy testing markets. The global minimal residual disease dynamic monitor market is expected to grow with a CAGR of 16.1% from 2025 to 2031. The major drivers for this market are rising focus on early detection and minimal relapse, increasing adoption of precision medicine, and growing prevalence of hematological cancers.
A more than 150-page report to understand trends, opportunity and forecast in minimal residual disease dynamic monitor market to 2031 by type (blood tumor MRD dynamic monitor and solid tumor MRD dynamic monitor), application (adjuvant therapy testing, prognostic assessment, postoperative recurrence detection, immunotherapy efficacy testing, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, blood tumor MRD dynamic monitor is expected to witness higher growth over the forecast period due to increasing prevalence of hematological malignancies.
Within the application category, prognostic assessment will remain the largest segment.
Download sample by clicking on minimal residual disease dynamic monitor market
In terms of region, North America is expected to witness the highest growth over the forecast period due to its advanced healthcare infrastructure and regulatory support.
BGI Genomics, OrigiMed, Burning Rock Biotech, Predicine, Genecast, 3D Medicines, Gene+ are the major suppliers in the minimal residual disease dynamic monitor market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Solar Microinverter Market
Adult Vaccine Market
Diphtheria Vaccine Market
Hepatitis A Vaccine Market
Pediatric Vaccine Market